Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03746106 · ClinicalTrials.gov registry record · Phase 4
The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
A Phase 4 study of Thiamine Deficiency and Vitamin B1 Deficiency, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03746106 is a Phase 4 study of Thiamine Deficiency and Vitamin B1 Deficiency that has completed, run by University of California, San Francisco. The registered enrollment target is 7 participants, below the 122-participant average among 3 other Thiamine Deficiency trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03746106, a Phase 4 study of Thiamine Deficiency and Vitamin B1 Deficiency, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
In Part 1, subjects will be administered thiamine, thiamine with metformin, and thiamine with trimethoprim. Part 2 will expand on Part 1 and subjects will be administered thiamine and thiamine with trimethoprim. The goal is to determine whether taking a drug and a vitamin together affects the body's ability to absorb, distribute, and eliminate thiamine (Vitamin B1).
Conditions Studied
Interventions
- DRUG Metformin
- DRUG Trimethoprim
- DIETARY_SUPPLEMENT Vitamin B1
Study Locations (1)
Massachusetts
- Jean Mayer USDA Human Nutrition Research Center on Aging - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2023-08-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03746106
The ClinicalTrials.gov registry entry for NCT03746106 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 122-participant average among 3 other Thiamine Deficiency trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thiamine Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Metformin is the first listed.
NCT03746106 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03746106 about?
NCT03746106 is a clinical study titled "The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine". In Part 1, subjects will be administered thiamine, thiamine with metformin, and thiamine with trimethoprim. Part 2 will expand on Part 1 and subjects will be administered thiamine and thiamine with trimethoprim. The goal is to determine whether taking a drug and a vitamin together affects the body's...
What is the current status of trial NCT03746106?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2019-01-28. Estimated completion is 2023-08-10.
What conditions does trial NCT03746106 study?
This clinical trial studies the following conditions: Thiamine Deficiency, Vitamin B1 Deficiency.
What interventions are being tested in trial NCT03746106?
The interventions under investigation include: Metformin (DRUG), Trimethoprim (DRUG), Vitamin B1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03746106?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03746106 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thiamine Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.